ERBC (European Research Biology Center)
Silvana Venturella currently serves as COO, General Manager, and Test Facility Director at the European Research Biology Center since January 2021. Previously, Venturella held the role of Associate Scientific Director and Head of Business Unit in vivo Toxicology at Research Toxicology Centre from December 1991 to February 2020, overseeing compliance with Good Laboratory Practice regulations and enhancing communication and efficiency within scientific operations. Venturella also contributed as a Project Manager, assisting in staffing and operational readiness for studies, and began their career as Assistant to the Scientific Director at ETI - Ente Tabacchi Italiano. Silvana Venturella holds a Laurea in Biology from Università degli Studi di Palermo and a Master's degree in Regulatory Disciplines from Università di Pavia.
This person is not in any offices
ERBC (European Research Biology Center)
Stemming from the merger of two reference CROs in pharmacology and toxicology (CERB and RTC), European Research Biology Center (ERBC) is a European leader in non-clinical studies. It offers to healthcare and chemical professionals a comprehensive range of experimental capabilities, preclinical models, regulatory pre-IND package and consultancy services to de-risk innovation and improve R&D productivity. Based in Baugy (France) and Roma (Italy), ERBC provides all services from preclinical proof-of-concept to market of any type of drug candidate or chemical compound. Each project is managed by a study director, relying on a multi-disciplinary team of experts, notably in general pharmacology, cardiology, electrophysiology and pathophysiology, also benefiting from a world class academic and private network. Every year, study reports from our two Centers are successfully used in support of market authorization and new product approval submissions around the world, including the European (EMA, ECHA), US (FDA and EPA) and Japanese (MHLW and MAFF) regulatory authorities. Investment in outstanding scientific and technical manpower, high-tech equipment and facilities are crucial cornerstones of our sound and organic growth. The quality and reliability of our performance is reflected by the many ongoing and long-lasting collaborations we maintain with leading international pharmaceutical and chemical companies. ERBC is deeply engaged in animal ethics and welfare. ERBC supports the Basel Declaration, respects the 3Rs concept and continually improves its tools and procedures to maximize the balance between the benefit for health and the animal well-being.